A new look at triple-negative breast cancer
By Jan Jarvis
Researchers at UNT Health Science Center have received a $1.9 million grant from the National Cancer Institute to help develop a new therapy that holds promise for the 38,000 to 55,000 women who are diagnosed with this disease each year.
Jamboor K Vishwanatha, PhD, and his colleagues – Pankaj Chaudhary, PhD, and Sumihiro Suzuki, PhD – will measure a protein called Annexin A2, which is shed from cancer cells and circulates in the blood. This protein leads to the aggressiveness of triple-negative breast cancer and its metastasis to other organs, said Dr.Vishwanatha, Regents Professor and Vice President for Diversity and International Programs.
“Our research could potentially lead to a biomarker that can predict aggressive TNBC metastasis in African-American women, and possibly lead to development of new therapeutic options for women with this type of breast cancer,” Dr. Vishwanatha said.
About 15 percent to 20 percent of breast cancers are triple-negative. This means that three common receptors known to fuel most breast cancer growth – estrogen, progesterone, and the HER-2/neu gene – are not present in the tumor. As a result, common treatments like hormone therapy and drugs that target estrogen, progesterone, and HER-2 are ineffective.
Triple-negative breast cancer is prevalent in women who carry a mutated copy of the BRCA1 gene and in women of African descent. Those who are diagnosed with TNBC have a high frequency of metastasis to the lung, liver and brain, and survival is generally poor.
African-American women with TNBC tend to have worse clinical outcomes compared with women of European descent who have the disease. The disease is often more aggressive in African-American women.
The research could lead to better treatments for those who are disproportionately affected by this disease, said Dr. Chaudhary, Research Assistant Professor in the Institute of Molecular Medicine.
“We predict the results arising from the proposed studies will lay the foundation for future studies to determine if circulating levels of Annexin A2 need to be taken into consideration during study design in metastasis detection, prognosis, and therapy for African-American patients with TNBC,” Dr. Chaudhary said.
Dr. Suzuki, Associate Professor and Chair of Biostatistics and Epidemiology in the School of Public Health, will oversee data management, data cleaning and preparation, and data analyses.
To conduct this project, Dr. Vishwanatha is working with collaborators from across the country and around the world, including 14 institutions in Africa and Europe.
By Sally Crocker Three nationally known alcohol and substance abuse researchers -- Dr. Melissa A. Lewis, Dr. Dana M. Litt and Dr. Eun-Young Mun – have been appointed to the UNTHSC School of Public Health faculty, underlining the school’s intent to become a national center of excellence in...Read more
Jan 22, 2018
By Jan Jarvis Forty-six UNT Health Science Center physicians have been recognized as Top Doctors, as selected by their peers for listings in Texas Monthly, Fort Worth Magazine and 360 West. Three UNTHSC physicians from Geriatrics have been recognized as Super Doctors by Texas Monthly...Read more
Jan 18, 2018
By Jan Jarvis As someone who enjoys a good meal, Molly Chang was eager to sample the different dishes that are cooked each week in the Culinary Medicine course. “I love trying out recipes and eating new foods, so cooking with friends and getting a free meal is right up my alley,”...Read more
Jan 17, 2018
By Alex Branch A 2015 School of Health Professions graduate will help put injured Miami Marlins baseball players back on the playing field this summer. Steve Carlin PT, DPT, will treat players throughout the organization as the rehabilitation coordinator at the Marlins spring training faci...Read more
Jan 9, 2018